Artios Pharma

Artios Pharma

Artios Pharma

Artios is a leading independent DNA Damage Response (DDR) company focussed on developing firstinclass treatments for cancer.
Founded
2016
Raised
$119.3M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
£65,000,000
Venture capital (Series B) - 2018
Novartis Venture Fund Life Sciences Partners IP Group Plc +7
£25,000,000
Undisclosed
Team Size
2
Employees
$33,200,000 Venture capital (Series A)
FinSMEs

Artios Pharma Raises $33.2M in Series A Funding

Funding Health